Accendra Health, Inc. (ACH) Financial Statements
Accendra Health, Inc. (ACH) reported trailing twelve-month revenue of $2.6B (down 3.3% year on year) and net income of -$302.1M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$303.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ACHAccendra Health, Inc.Follow ACH — free
—
Price chart with a free account
- Market cap
- 16.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.12 | 8.63 | 8.87 | 9.07 | 9.44 | 9.77 | 9.72 | 9.32 | 9.42 | 9.21 | 8.48 | 9.79 | 9.96 | 2.55 | 2.68 | 2.76 | 2.65 | |
| Gross profit | 0.81 | 0.86 | 0.92 | 1.12 | 1.17 | 1.21 | 1.19 | 1.17 | 1.07 | 1.13 | 1.28 | 1.51 | 1.83 | 2.13 | 2.22 | 1.29 | 1.19 | |
| Research & development | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.01 | 0.01 | — | — | |
| Operating income | 0.20 | 0.20 | 0.20 | 0.20 | 0.16 | 0.20 | 0.20 | 0.09 | -0.35 | 0.07 | 0.20 | 0.37 | 0.14 | 0.13 | -0.22 | 0.03 | 0.03 | |
| Pre-tax income | 0.18 | 0.19 | 0.18 | 0.18 | 0.13 | 0.17 | 0.17 | 0.06 | -0.43 | -0.03 | 0.11 | 0.28 | 0.01 | 0.02 | -0.33 | -0.10 | -0.12 | |
| Income tax | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 | 0.06 | -0.02 | -0.03 | -0.01 | 0.02 | 0.06 | -0.01 | 0.01 | 0.02 | 0.00 | -0.00 | |
| Net income | 0.11 | 0.12 | 0.11 | 0.11 | 0.07 | 0.10 | 0.11 | 0.07 | -0.44 | -0.06 | 0.03 | 0.22 | 0.02 | -0.04 | -0.36 | -1.10 | -0.30 | |
| Diluted EPS ($) | 1.75 | 1.81 | 1.72 | 1.76 | 1.06 | 1.65 | 1.76 | 1.20 | -7.28 | -1.03 | 0.47 | 2.94 | 0.29 | -0.53 | -4.73 | -14.31 | -3.94 | |
| Diluted shares (bn) | — | 0.063 | 0.063 | 0.063 | 0.062 | 0.062 | 0.061 | 0.060 | — | 0.061 | 0.064 | 0.075 | 0.076 | 0.077 | 0.077 | 0.077 | — |
USD billions · SEC XBRL
Accendra Health, Inc. — questions
- What is Accendra Health, Inc.'s revenue?
- $2.6B over the twelve months to 2026-06-30, down 3.3% year on year, from its 10-Q and 10-K filings.
- What is Accendra Health, Inc.'s net income?
- -$302.1M over the twelve months to 2026-06-30.
- What is Accendra Health, Inc.'s free cash flow?
- -$303.1M over the twelve months to 2026-06-30.
- What are Accendra Health, Inc.'s diluted earnings per share?
- $-3.94 over the twelve months to 2026-06-30.
Every figure on this page comes from Accendra Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.